These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
374 related articles for article (PubMed ID: 15832504)
1. Molecular properties of WHO essential drugs and provisional biopharmaceutical classification. Kasim NA; Whitehouse M; Ramachandran C; Bermejo M; Lennernäs H; Hussain AS; Junginger HE; Stavchansky SA; Midha KK; Shah VP; Amidon GL Mol Pharm; 2004 Jan; 1(1):85-96. PubMed ID: 15832504 [TBL] [Abstract][Full Text] [Related]
2. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. Takagi T; Ramachandran C; Bermejo M; Yamashita S; Yu LX; Amidon GL Mol Pharm; 2006; 3(6):631-43. PubMed ID: 17140251 [TBL] [Abstract][Full Text] [Related]
3. Purely in silico BCS classification: science based quality standards for the world's drugs. Dahan A; Wolk O; Kim YH; Ramachandran C; Crippen GM; Takagi T; Bermejo M; Amidon GL Mol Pharm; 2013 Nov; 10(11):4378-90. PubMed ID: 24094040 [TBL] [Abstract][Full Text] [Related]
4. Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system. Lindenberg M; Kopp S; Dressman JB Eur J Pharm Biopharm; 2004 Sep; 58(2):265-78. PubMed ID: 15296954 [TBL] [Abstract][Full Text] [Related]
5. Integrating theoretical and experimental permeability estimations for provisional biopharmaceutical classification: Application to the WHO essential medicines. Cabrera-Pérez MÁ; Pham-The H; Cervera MF; Hernández-Armengol R; Miranda-Pérez de Alejo C; Brito-Ferrer Y Biopharm Drug Dispos; 2018 Jul; 39(7):354-368. PubMed ID: 30021059 [TBL] [Abstract][Full Text] [Related]
6. Provisional classification and in silico study of biopharmaceutical system based on caco-2 cell permeability and dose number. Pham-The H; Garrigues T; Bermejo M; González-Álvarez I; Monteagudo MC; Cabrera-Pérez MÁ Mol Pharm; 2013 Jun; 10(6):2445-61. PubMed ID: 23675957 [TBL] [Abstract][Full Text] [Related]
7. Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs. Dahan A; Miller JM; Amidon GL AAPS J; 2009 Dec; 11(4):740-6. PubMed ID: 19876745 [TBL] [Abstract][Full Text] [Related]
8. The biowaiver extension for BCS class III drugs: the effect of dissolution rate on the bioequivalence of BCS class III immediate-release drugs predicted by computer simulation. Tsume Y; Amidon GL Mol Pharm; 2010 Aug; 7(4):1235-43. PubMed ID: 20557130 [TBL] [Abstract][Full Text] [Related]
9. Solubility Determination of Active Pharmaceutical Ingredients Which Have Been Recently Added to the List of Essential Medicines in the Context of the Biopharmaceutics Classification System-Biowaiver. Plöger GF; Hofsäss MA; Dressman JB J Pharm Sci; 2018 Jun; 107(6):1478-1488. PubMed ID: 29421214 [TBL] [Abstract][Full Text] [Related]
11. Biopharmaceutical optimization in neglected diseases for paediatric patients by applying the provisional paediatric biopharmaceutical classification system. Del Moral Sanchez JM; Gonzalez-Alvarez I; Cerda-Revert A; Gonzalez-Alvarez M; Navarro-Ruiz A; Amidon GL; Bermejo M Br J Clin Pharmacol; 2018 Oct; 84(10):2231-2241. PubMed ID: 29846973 [TBL] [Abstract][Full Text] [Related]
12. Applying Biopharmaceutical Classification System (BCS) Criteria to Predict Oral Absorption of Drugs in Dogs: Challenges and Pitfalls. Papich MG; Martinez MN AAPS J; 2015 Jul; 17(4):948-64. PubMed ID: 25916691 [TBL] [Abstract][Full Text] [Related]
13. Establishing the pharmaceutical quality of Chinese herbal medicine: a provisional BCS classification. Fong SY; Liu M; Wei H; Löbenberg R; Kanfer I; Lee VH; Amidon GL; Zuo Z Mol Pharm; 2013 May; 10(5):1623-43. PubMed ID: 23473440 [TBL] [Abstract][Full Text] [Related]
14. The Biopharmaceutics Classification System: subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC. Tsume Y; Mudie DM; Langguth P; Amidon GE; Amidon GL Eur J Pharm Sci; 2014 Jun; 57():152-63. PubMed ID: 24486482 [TBL] [Abstract][Full Text] [Related]
15. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies. Cristofoletti R; Chiann C; Dressman JB; Storpirtis S J Pharm Sci; 2013 Sep; 102(9):3136-44. PubMed ID: 23580377 [TBL] [Abstract][Full Text] [Related]
16. Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development. Wolk O; Agbaria R; Dahan A Drug Des Devel Ther; 2014; 8():1563-75. PubMed ID: 25284986 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the use of partition coefficients and molecular surface properties as predictors of drug absorption: a provisional biopharmaceutical classification of the list of national essential medicines of Pakistan. Shawahna R; Rahman N Daru; 2011; 19(2):83-99. PubMed ID: 22615645 [TBL] [Abstract][Full Text] [Related]
18. Provisional biopharmaceutical classification of some common herbs used in Western medicine. Waldmann S; Almukainzi M; Bou-Chacra NA; Amidon GL; Lee BJ; Feng J; Kanfer I; Zuo JZ; Wei H; Bolger MB; Löbenberg R Mol Pharm; 2012 Apr; 9(4):815-22. PubMed ID: 22352942 [TBL] [Abstract][Full Text] [Related]